Our ovarian cancer nomogram is an online tool that can be used to help predict the chance that a patient will not survive five years after primary surgery for epithelial ovarian cancer.
Who Can Use This Tool?
This tool can be used primarily by physicians to help them counsel patients, determine clinical trial eligibility, choose postoperative management techniques, and select a follow-up care plan.
This nomogram was developed using information from women with any stage of epithelial ovarian cancer who had surgery to remove their tumor. Therefore, this nomogram should not be used for women who have not had surgical treatment.
Patients should only use this tool in consultation with their physicians to understand their prognosis after surgery for epithelial ovarian cancer.
Why Is This Tool Useful?
Doctors have traditionally relied on the International Federation of Gynecology and Obstetrics (FIGO) staging system to estimate survival for epithelial ovarian cancer. However, additional patient- and tumor-specific factors may be important in determining prognosis.
This prediction tool takes those factors – including age, tumor type, family history, and overall physical health – into account.
What Information Will You Need?
For this nomogram to provide an accurate prediction of survival at five years after primary surgery for epithelial ovarian cancer, you need to include accurate values for all of the information below.
- Age: Patient’s age at the time of the diagnosis.
- Tumor Stage: Based on the 1986 FIGO staging system.
- Size of Tumor Remaining after Primary Surgery: None, greater than or equal to 1.0 cm, or greater than 1.0 cm.
- Albumin Level Before Surgery: Based on blood test results.
- Tumor Type: The specific subtype of ovarian cancer determined by a pathologist after surgery.
- Family History Suggestive of Hereditary Breast/Ovarian Cancer (HBOC) Syndrome: Yes or no. Patients of Jewish background considered yes if they have a personal or family history of breast cancer, or family history of ovarian cancer. Other patients considered yes if they have a personal history of breast cancer, family history of breast cancer before age 50, or ovarian cancer at any age.
- American Society of Anesthesiologists (ASA) Score: I-III, based on the physical health of the patient.
To better understand these results, patients who elect to use this tool should discuss the survival estimates provided by this nomogram with their doctors.
Use our epithelial ovarian cancer nomogram.
If you have questions or comments about this tool, please contact us at email@example.com.